V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 70064017 | 70153721 | 0 | 0 | null | 2018-08-16 | 2018-10-18 | IMATINIB | 02 | null | IMATINIB | 101871601 |
| 70064017 | 70169570 | 0 | 12.1 | null | 2018-08-03 | 2018-11-10 | ALL UKALL2011 Maintenance B1 | 01 | null | ALL UKALL2011 MAINTENANCE | 101871601 |
| 70064017 | 70095620 | 1.57 | 109.4 | Curative (C) | 2018-01-13 | 2018-09-11 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | TRIAL UNSPECIFIED | 101871601 |
| 70064017 | 70041012 | 1.86 | 70 | 03 | 2018-08-15 | 2018-08-15 | CVP R | 02 | Y | ABVD | 101871601 |
| 70064017 | 70130315 | 1.87 | 70.6 | null | 2018-09-18 | 2018-09-18 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101871601 |
| 30144443 | 30070570 | 1.68 | 108 | Palliative (P) | 2019-03-03 | 2019-03-03 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101871597 |
| 100033581 | 100110300 | 1.75 | 79.6 | Palliative (P) | 2019-12-07 | 2020-01-03 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101871589 |
| 100033581 | 100075507 | 1.64 | 51.1 | Palliative (P) | 2019-11-28 | 2019-12-13 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101871589 |
| 40146455 | 40104818 | 1.6 | 92.5 | Curative (C) | null | 2019-02-17 | EC | N | N | EC | 101871583 |
| 110016004 | 110001564 | 1.7 | 63 | null | 2020-08-12 | 2020-08-26 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101871580 |
| 110016004 | 110005887 | null | null | null | null | 2020-10-02 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101871580 |
| 70071104 | 70098023 | 1.62 | 63 | Curative (C) | 2016-08-27 | 2016-09-02 | POMALIDOMIDE | 01 | N | METHOTREXATE INTRATHECAL | 101871578 |
| 70071104 | 70045495 | 1.66 | 96 | Palliative (P) | 2016-08-31 | 2016-09-01 | CVD | N | N | CVD | 101871578 |
| 70071104 | 70132076 | 1.58 | 70 | Curative (C) | 2016-10-04 | 2016-10-04 | AML 19 TRIAL | 01 | N | AML19 TRIAL | 101871578 |
| 70019593 | 70078509 | 1.74 | null | Curative (C) | 2018-06-25 | 2018-06-26 | Rituximab | 02 | N | RITUXIMAB | 101871572 |
| 70019593 | 70015023 | null | null | Curative (C) | 2016-09-27 | 2016-10-04 | CHOP R | 02 | N | CHOP R | 101871572 |
| 230002456 | 230002456 | null | null | null | null | 2018-03-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101871570 |
| 230002456 | 230006882 | 1.6 | 67 | null | 2018-11-16 | 2018-11-19 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101871570 |
| 230002456 | 230010232 | 1.56 | 56.7 | null | 2021-02-01 | 2021-02-06 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101871570 |
| 230002456 | 230011393 | 1.58 | 64.3 | null | 2021-04-06 | 2021-04-18 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101871570 |
| 230002456 | 230011575 | 1.63 | 98.3 | null | 2020-09-21 | 2021-05-16 | null | 02 | null | TRASTUZUMAB EMTANSINE | 101871570 |
| 230002456 | 230011842 | 1.67 | 86.5 | null | 2020-12-07 | 2021-04-16 | null | null | null | BEVACIZUMAB | 101871570 |
| 230002456 | 230010762 | 1.58 | 53 | Palliative (P) | 2021-03-07 | 2021-03-08 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101871570 |
| 110032774 | 110006651 | 1.68 | 99.8 | Palliative (P) | 2020-05-23 | 2020-06-13 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101871552 |
| 60094044 | 60034868 | 1.62 | 79.8 | Palliative (P) | 2018-05-10 | 2018-05-17 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + VINORELBINE | 101871546 |
| 60094044 | 60060320 | 1.51 | 61 | Palliative (P) | 2018-04-30 | 2018-05-18 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 101871546 |
| 60094044 | 60075022 | 1.52 | 72.2 | Palliative (P) | 2018-07-25 | 2018-08-01 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101871546 |
| 60094044 | 60082658 | 1.76 | 89.4 | Palliative (P) | 2018-10-15 | 2018-10-24 | Atezolizumab | 02 | N | ATEZOLIZUMAB | 101871546 |
| 70084809 | 70053924 | 1.7 | 61 | 03 | 2016-09-30 | 2016-10-03 | CTD Attenuated (Thalidomide 50mg) | N | N | CTD | 101871538 |
| 70084809 | 70103354 | 1.86 | 18.2 | 03 | 2016-11-22 | 2016-12-06 | UKALL14- Maintenance | 02 | Y | UKALL2014 | 101871538 |
| 120003321 | 120001813 | 1.52 | 93.6 | 03 | 2017-05-01 | 2017-05-02 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101871531 |
| 40160513 | 40247474 | null | 71.7 | Adjuvant (A) | null | 2018-04-24 | DOCETAXEL + TRASTUZUMAB | 2 | N | DOCETAXEL + TRASTUZUMAB | 101871530 |
| 40160513 | 40279281 | 1.72 | 81 | Palliative (P) | 2019-01-02 | 2019-01-03 | Capecitabine | 02 | N | CAPECITABINE | 101871530 |
| 40160513 | 40195748 | 1.79 | 57.4 | Adjuvant (A) | 2017-04-08 | 2018-04-03 | FEC 100 + DOCETAXEL | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101871530 |
| 40160513 | 40114954 | 1.63 | 61 | Adjuvant (A) | null | 2018-03-14 | PACLITAXEL + TRASTUZUMAB | 02 | N | PACLITAXEL + TRASTUZUMAB | 101871530 |
| 60098830 | 60036653 | 1.53 | 72.2 | Adjuvant (A) | 2019-04-05 | 2019-04-06 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + VINORELBINE | 101871506 |
| 60098830 | 60061450 | 1.73 | 65.5 | Palliative (P) | 2021-04-24 | 2021-10-08 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101871506 |
| 20157452 | 20060101 | 1.68 | 44.8 | Neo-adjuvant (N) | 2018-11-09 | 2018-11-30 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101871503 |
| 60085165 | 60031516 | 1.58 | 54.1 | Palliative (P) | 2017-06-29 | 2017-06-29 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 101871494 |
| 70029672 | 70022296 | 1.64 | 137 | Palliative (P) | 2018-02-18 | 2018-02-18 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 101871492 |
| 80057693 | 80032106 | 1.57 | 87 | null | 2020-03-10 | 2020-03-25 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101871491 |
| 80057693 | 80046025 | 1.52 | 0 | null | 2021-05-19 | 2021-05-25 | CABOZANTINIB | 02 | null | CABOZANTINIB | 101871491 |
| 80057693 | 80040885 | 0 | 72.5 | 03 | 2019-03-21 | 2021-03-27 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101871491 |
| 80057693 | 80016680 | 1.73 | 0 | null | 2019-12-01 | 2019-12-31 | BCG Intravesical | 02 | N | BACILLUS CALMETTE-GUERIN | 101871491 |
| 90040756 | 90044684 | 1.5 | 84.05 | Adjuvant (A) | 2017-01-02 | 2017-01-08 | Carboplatin AUC 6 - 10 | N | N | CARBOPLATIN | 101871488 |
| 90040756 | 90018430 | 1.65 | 68 | Curative (C) | 2016-09-16 | 2016-09-17 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101871488 |
| 70019161 | 70014687 | 1.76 | 99.6 | Curative (C) | 2017-08-02 | 2017-08-02 | CHOP R - 21 days | 2 | N | CHOP R | 101871483 |
| 70019161 | 70078272 | 1.7 | 94.2 | 03 | 2017-07-28 | 2017-08-02 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | RITUXIMAB | 101871483 |
| 20143004 | 20051708 | 1.54 | 108 | Palliative (P) | 2018-07-15 | 2018-07-21 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 101871481 |
| 60102834 | 60089005 | 1.59 | 58.5 | null | 2021-01-07 | 2021-01-11 | Carboplatin + Pemetrexed | 02 | null | CARBOPLATIN + PEMETREXED | 101871475 |